2. The Frozen Court

The Crofton Correctional Immigration Detention Ward sat on a reclaimed industrial peninsula twenty miles east of Portovaya, a low-slung concrete complex that had once been a poultry processing plant. The conversion had been minimal: the kill floor became a processing center, the cold storage lockers became holding cells, and the drainage channels that had once carried animal blood now carried gray water from the communal showers. The building retained a faint, permanent smell of ammonia and old fear.

Rafiq Nazari had been inside for six days.

His cell was a concrete box measuring eight feet by ten, with a steel toilet, a narrow cot bolted to the wall, and a single fluorescent tube overhead that never turned off. The light buzzed at a frequency that made his teeth ache. He slept in increments of twenty or thirty minutes, waking each time the guard walked past and rapped a baton against the bars. Sleep deprivation, he understood, was part of the intake protocol. It softened people up. Made them compliant.

The expedited removal hearing was scheduled for Monday morning. He had no lawyer. The legal aid office inside Crofton was understaffed and overwhelmed, and his case—stateless, aggravated felony, Tier One security breach—was considered a low priority. The intake officer who had processed him, a heavyset man with nicotine-stained fingers and a practiced indifference, had explained this without looking up from his screen: "Best case, you get a five-minute phone consultation before the judge rules. Worst case, you're on a charter flight to the Khorasani Interim Zone by Tuesday."

The Khorasani Interim Zone. The phrase was a bureaucratic euphemism for a stretch of contested territory that no functioning government claimed. It was not a country. It was a gap on the map, a scar left behind by a war that had technically ended but never really stopped. The people who lived there—the ones who had not managed to flee—survived on aid shipments that arrived irregularly and were often looted before distribution. Returning there as a deportee with a drug trafficking record was, Rafiq understood, a death sentence delivered slowly.

On the seventh day, a visitor came.

Her name, according to the visitor log that the guard slid under his door, was Elena Voss. She was identified as a legal aid volunteer with the Portovaya Immigrant Justice Collective, an organization Rafiq had never heard of. The log included a small photograph, pixelated from the cheap printer: a pale woman in her late thirties, dark hair pulled back tightly, eyes that seemed to be squinting at something just outside the frame.

The visitation room was a long, narrow space divided by a plexiglass barrier. Rafiq sat on one side, a plastic chair bolted to the floor. Elena Voss sat on the other. She was thinner than her photograph suggested, with sharp cheekbones and a small scar above her left eyebrow that moved when she spoke. She wore a gray blazer over a black turtleneck, the uniform of a certain kind of professional woman in Portovaya—lawyers, journalists, mid-level corporate functionaries. But there was something about the way she held herself, a coiled stillness, that didn't quite fit the type.

"Mr. Nazari," she said. Her voice was low and even, the accent educated Virelian with a trace of something else beneath it—a regional inflection Rafiq couldn't place. "I'm here to discuss your case."

"I don't have a case," Rafiq said. "I have a removal order waiting for a signature."

"That's not entirely accurate." She opened a thin folder on the counter in front of her. The folder contained several pages of printed documents, some of them stamped with official seals. "Your removal is being pursued under Code 287G, the aggravated felony provision. But the aggravated felony designation depends on the original conviction being for drug trafficking, which in turn depends on the substance involved meeting a specific statutory threshold. Your conviction was for three grams of fen-C. That's a borderline quantity. I've seen similar cases where the trafficking charge was reduced to simple possession on appeal."

Rafiq studied her face through the plexiglass. "That appeal would have had to happen seven years ago. The deadline is long past."

"It is." She didn't blink. "But the Immigration Compliance Court has discretionary authority to reconsider old convictions if new evidence emerges regarding the original prosecution. It's rarely used, but it exists."

"What new evidence?"

"That's what I'm trying to find." She closed the folder and leaned forward slightly. "Mr. Nazari, I'm going to be honest with you. I'm not just here about your case. I'm investigating OmniGen Laboratories. I've been investigating them for eighteen months."

The fluorescent light buzzed overhead. Rafiq felt the scarab on his ankle, dormant now but always present, a constant pressure against his skin.

"Investigating them for what?" he asked.

"For a range of things. Securities fraud. Sanctions violations. Unauthorized human subject research." She said the last phrase carefully, spacing out the words. "I have sources inside the company who've been feeding me documents. Low-level employees, mostly. Lab techs, administrative staff. People who signed nondisclosure agreements and then realized what they weren't allowed to disclose."

"And what does this have to do with me?"

"Three weeks ago, one of my sources told me about a project called Chimera. It's a gene-editing initiative housed in the Pre-Embryonic Containment Bay. The project's official purpose is to develop synthetic organoids for transplant therapy—lab-grown tissues that can replace damaged organs without rejection risk. It's OmniGen's flagship R&D pipeline. Their entire valuation is built on it."

Rafiq said nothing. The word "Chimera" was still echoing in his head, the stenciled letters on the pod: CHIMERA-7.

"But my source told me something else," Elena continued. "The organoids aren't just being grown in vitro. They're being grown inside human surrogates. Undocumented migrants, mostly. People who can't refuse because refusal means deportation. OmniGen offers them something called a 'gene-therapy credit'—essentially, a promise of free medical treatment for themselves or their families in exchange for serving as incubation hosts. The treatment never materializes. But the organoids do."

Rafiq's throat was dry. "How do you know this?"

"Because I've interviewed three of the surrogates. Two of them are dead now. The third is in hiding, somewhere in the Azurian archipelago. She told me that the surrogates are kept in a separate facility, not the main Portovaya tower. A place called the Sanctuary Lab, on an island called Scáthach. She said the organoids aren't just organs. Some of them are whole organisms. Hybrids. Chimeras. They're being designed with specific genetic triggers—kill switches, essentially—that can be activated remotely."

"Kill switches for what?"

"For the surrogates." Elena's voice dropped to barely above a whisper. "The surrogates are all of Khorasani descent, Mr. Nazari. Every single one. The chimeras are coded to recognize Khorasani genomic markers. When the project is terminated, the chimeras are designed to seek out and eliminate anyone carrying those markers. It's a cleanup protocol. A biological self-destruct."

Rafiq felt the cold thing in his stomach open wider. He thought about the creature in the pod, the gray-green sac of tissue sliding through the ventilation grate. He thought about the silver wires embedded in its translucent body.

"The pod that broke," he said slowly. "It was labeled C7. CHIMERA-7."

Elena's eyes sharpened. "You saw it?"

"It wasn't an organoid. It was alive. It moved. It crawled into the vents."

For a long moment, Elena said nothing. She stared at him through the plexiglass, her expression unreadable. Then she opened her folder again and pulled out a single photograph. It was a satellite image, grainy and slightly distorted, showing a small island surrounded by dark water. A single building stood at the island's center, a rectangular structure with a flat roof and no windows.

"This is Scáthach," she said. "The Sanctuary Lab. It's a volcanic atoll in international waters, technically outside Virelian jurisdiction. OmniGen purchased it through a shell company five years ago. The company is called Harrow Equity—a venture capital syndicate that specializes in funding controversial biotech projects that can't get approval in regulated markets. They've backed everything from cognitive enhancement implants to germline editing for cosmetic traits. Chimera is their biggest bet. If it succeeds, the organoid market alone is worth an estimated three hundred billion federated dollars. If it fails, they'll burn everything—the lab, the data, the surrogates—and walk away clean."

Rafiq looked at the photograph. The island seemed to float on the dark water like a coffin lid. "Why are you telling me this?"

"Because you're the only person who's seen a live chimera and survived. The surrogates who saw them are dead. The lab techs who worked on the early stages were transferred to other facilities and signed new NDAs with enhanced penalty clauses—up to and including loss of citizenship for anyone who talks. But you're already stateless, Mr. Nazari. You have no citizenship to lose. And your removal hearing is on Monday. After that, you'll be on a plane to a place where OmniGen's contractors can reach you within hours."

She leaned closer to the plexiglass. Her breath fogged the surface, a small circle of condensation that vanished as quickly as it appeared.

"I can file an emergency motion to delay your removal," she said. "It won't stop the proceeding, but it might buy us a week, maybe two. Enough time to get the documents my source has been stockpiling. Enough time to prove that the aggravated felony charge was part of a pattern—that OmniGen has been using immigration enforcement as a tool to silence witnesses. But I need something from you in return."

"What?"

"When you were in the cleanroom, you were wearing a body camera. All OmniGen custodial staff are required to wear them—company policy, for liability reasons. The footage is stored on a local server for seventy-two hours before being uploaded to the corporate cloud. That means your footage from the night of the breach should still exist on the tower's internal network. If I can get access to that footage, it would corroborate everything. It would prove the chimera was real."

Rafiq remembered the body camera. A small black device clipped to the chest of his uniform, its red light blinking steadily throughout his shift. He had forgotten about it entirely in the chaos of the security team's arrival.

"The camera uploads automatically," he said. "I don't have access to the footage."

"I know. But I have a source in OmniGen's IT department. Someone who can pull the file, if they know exactly when and where to look. What time did the breach occur?"

"0247. Pre-Embryonic Containment Bay Seven."

Elena wrote this down on a small notepad. "Anything else? Anything you remember about the chimera? Its size, its behavior?"

"It was about the size of a cat. Translucent. There were wires inside it—silver wires, like electrodes. It didn't have a head, but there were specks that looked like eyes. And it compressed itself to fit through the ventilation grate. Flattened out like a slug."

Elena's pen stopped moving. She looked up at him, and for the first time, Rafiq saw something flicker behind her professional composure. It might have been fear.

"Silver wires," she repeated. "That's a neural lattice. A synthetic nervous system, grown from modified stem cells. It means the chimera isn't just a biological construct. It's a biocomputer. It can receive signals. It can be directed."

"Directed to do what?"

"I don't know. But if it escaped into the tower's ventilation system, and if it's still alive..." She closed her notepad and stood up. "I need to make some calls. I'll file the emergency motion this afternoon. In the meantime, don't talk to anyone—not the guards, not the other detainees, not the intake officers. Anyone in this facility could be on OmniGen's payroll."

She knocked on the visitation room door, and the guard outside opened it. Before she left, she turned back to Rafiq one last time.

"Your cousin," she said. "Sami. He died on a fishing boat off the Azurian coast, didn't he?"

Rafiq felt his chest tighten. "How do you know about Sami?"

"Because the boat wasn't a fishing boat. It was a transport vessel, carrying migrants from the Khorasani enclaves to Portovaya. And it didn't sink by accident. It was intercepted by a private naval contractor working for Harrow Equity. The passengers were taken to Scáthach." She paused. "I think your cousin might have been one of the first surrogates."

And then she was gone, the door closing behind her with a heavy metallic click.

That night, Rafiq lay on his cot and stared at the buzzing fluorescent tube. His mind was a churn of images: the pod fracturing, the creature sliding through the grate, the satellite photograph of the windowless building on the dark island. Sami's face, which he had tried for seven years not to think about, kept surfacing—Sami laughing on the deck of the boat, Sami handing him the backpack with the fen-C, Sami saying, "It's just painkillers, brother. For the journey."

The journey. What journey? Sami had never said where they were going, only that a contact in Portovaya had promised them work—steady work, with housing and documentation. The kind of promise that stateless people learned to distrust instinctively but could never quite afford to refuse.

Had Sami known about OmniGen? Had he been recruited as a surrogate? The timeline fit. Seven years ago, Sami disappeared from the enclaves for three months before returning with money and a backpack full of fen-C. He had been secretive about where he'd been, deflecting questions with jokes and vague references to "a medical study" that paid well. Rafiq had assumed it was a pharmaceutical trial—the kind that recruited desperate people and paid them a pittance to test experimental drugs. It happened all the time in the enclaves. No one asked questions because the alternative was starvation.

But what if it wasn't a drug trial? What if Sami had been carrying something inside him—something synthetic, something that bore the label CHIMERA?

At 0300, the guard rapped his baton against the bars, and Rafiq woke from a half-dream in which he was drowning in pink nutrient broth. He sat up, gasping. The fluorescent tube buzzed. The scarab on his ankle was silent.

And then he heard it.

A sound from the ventilation grate in the corner of his cell. A wet, squelching rhythm. Contracting and expanding.

He turned his head slowly. The grate was a small square of rusted metal set into the concrete wall near the floor, its slats clogged with dust and grime. Through the slats, in the darkness beyond, something was moving. Something the size of a cat. Something translucent, shot through with silver wires.

It pressed itself against the grate, and Rafiq saw the cluster of dark specks—the rudimentary eyes—turn toward him.

The creature had followed him.

It had crawled through the steel arteries of the OmniGen tower, out into the Portovaya streets, across twenty miles of urban sprawl and industrial wasteland, and into the ventilation system of Crofton Correctional. It had tracked him. It had been designed to track him.

Because he was Khorasani.

Because he carried the markers.

The creature stayed pressed against the grate for a long moment, its body pulsing with a faint blue-white light—the same light that had glowed inside the pod before it shattered. Then it contracted, flattening its body, and began to squeeze through the slats.